LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Aeolus Pharmaceuticals, Inc. (OTCBB:AOLS), today announced that it has raised $500,000 through the sale of newly issued Senior Convertible Notes and warrants to selected institutional investors. The investors also committed to invest another $500,000 over the next four months and have the option to invest an additional $4,000,000 over the next eighteen months.
